本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Aytu BioScience, Inc.

2.63
-0.0250-0.94%
盘后2.630.0060+0.23%19:55 EDT
成交量:12.18万
成交额:32.05万
市值:2,356.44万
市盈率:-3.15
高:2.70
开:2.65
低:2.55
收:2.65
数据加载中...
2023/07/10

重要事件披露

Form 8-K - Current report
2023/06/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/17

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/06/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/12

重要事件披露

Form 8-K - Current report
2023/06/09

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/06/07

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2023/06/07

SEC问询函

Form CORRESP - Correspondence
2023/06/07

SEC问询函

Form CORRESP - Correspondence
2023/06/06

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/05/27

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/22

重要事件披露

Form 8-K - Current report
2023/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/11

重要事件披露

8-K - Current report
2023/05/01

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2023/05/01

重要事件披露

8-K - Current report
2023/04/27

重要事件披露

8-K - Current report
2023/04/19

重要事件披露

8-K - Current report
2023/03/27

重要事件披露

8-K - Current report
2023/02/21

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]